Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
September 1, 2020
Waldenström Macroglobulinemia - 2020 Update on Management and Future Directions
Sheeba K Thomas
Clinical Lymphoma, Myeloma & Leukemia
|
January 4, 2022
SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions
Sheeba K Thomas
Blood Advances
|
March 31, 2026
Refining prognostic tools in Waldenström macroglobulinemia
Anath C Lionel, Sheeba K Thomas
Seminars in Oncology
|
May 19, 2012
Lymphoma vaccine therapy: next steps after a positive, controlled phase III clinical trial
Sheeba K Thomas, Larry W Kwak
Therapeutics and Clinical Risk Management
|
May 14, 2009
Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma
Jatin J Shah, Robert Z Orlowski, Sheeba K Thomas
Best Practice & Research. Clinical Haematology
|
December 12, 2007
Lenalidomide in multiple myeloma
Sheeba K Thomas, Tiffany A Richards, Donna M Weber
Cancer Journal (Sudbury, Mass.)
|
December 17, 2009
Novel agents for relapsed and/or refractory multiple myeloma
Sheeba K Thomas, Tiffany A Richards, Donna M Weber
Open Forum Infectious Diseases
|
February 18, 2016
Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy
Parag Mahale, Sheeba K Thomas, Andreas Kyvernitakis, et al.
Annals of Hematology
|
October 4, 2015
Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenström's macroglobulinemia
Walla A Alfaraj, David Cachia, Sudhakar Tummala, et al.
Hematological Oncology
|
February 8, 2025
Direct-Acting Antivirals Induce Lymphoproliferative Disease Response in HCV-Infected Patients With Indolent B-Cell Non-Hodgkin's Lymphoma: A Prospective Observational Study
Monica George, Khalis Mustafayev, Sairah Ahmed, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
Clinical Lymphoma, Myeloma & Leukemia
|
September 1, 2020
Waldenström Macroglobulinemia - 2020 Update on Management and Future Directions
Sheeba K Thomas
Clinical Lymphoma, Myeloma & Leukemia
|
January 4, 2022
SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions
Sheeba K Thomas
Blood Advances
|
March 31, 2026
Refining prognostic tools in Waldenström macroglobulinemia
Anath C Lionel, Sheeba K Thomas
Seminars in Oncology
|
May 19, 2012
Lymphoma vaccine therapy: next steps after a positive, controlled phase III clinical trial
Sheeba K Thomas, Larry W Kwak
Therapeutics and Clinical Risk Management
|
May 14, 2009
Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma
Jatin J Shah, Robert Z Orlowski, Sheeba K Thomas
Best Practice & Research. Clinical Haematology
|
December 12, 2007
Lenalidomide in multiple myeloma
Sheeba K Thomas, Tiffany A Richards, Donna M Weber
Cancer Journal (Sudbury, Mass.)
|
December 17, 2009
Novel agents for relapsed and/or refractory multiple myeloma
Sheeba K Thomas, Tiffany A Richards, Donna M Weber
Open Forum Infectious Diseases
|
February 18, 2016
Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy
Parag Mahale, Sheeba K Thomas, Andreas Kyvernitakis, et al.
Annals of Hematology
|
October 4, 2015
Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenström's macroglobulinemia
Walla A Alfaraj, David Cachia, Sudhakar Tummala, et al.
Hematological Oncology
|
February 8, 2025
Direct-Acting Antivirals Induce Lymphoproliferative Disease Response in HCV-Infected Patients With Indolent B-Cell Non-Hodgkin's Lymphoma: A Prospective Observational Study
Monica George, Khalis Mustafayev, Sairah Ahmed, et al.
Page
of 12